The application of anti-ALK antibody-conjugated liposomes in lung cancer is gradually gaining attention, especially in the treatment of non-small cell lung cancer (NSCLC) with ALK rearrangements. This therapeutic strategy combines the targeting ability of antibodies with the drug delivery characteristics of liposomes, potentially offering a more effective targeted treatment option.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0147 | Hi-Affi™ Rabbit Anti-ALK Recombinant Antibody (clone DS147AB) | IHC-P | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY35. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.